Investing.com - Merck reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.3 on revenue of €4.43B. Analysts polled by Investing.com anticipated EPS of €2.2 on revenue of €4.39B.
Merck shares are up 24% from the beginning of the year, still down 6.68% from its 52 week high of €140.35 set on November 9. They are outperforming the STOXX 600 which is down 7.38% from the start of the year.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings missed by Siemens AG on Thursday, who reported EPS of €1.2 on revenue of €15.31B, compared to forecasts EPS of €1.94 on revenue of €14.77B.
Bayer had missed expectations on November 3 with third quarter EPS of €0.81 on revenue of €8.51B, compared to forecast for EPS of €1.01 on revenue of €9.24B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar